<DOC>
	<DOCNO>NCT01821391</DOCNO>
	<brief_summary>This study conduct multi-centre , randomize , investigator-blind , active vehicle-controlled , intra-individual study . The purpose study confirm Metvix NDL-PDT procedure similar efficacy less painful compare Metvix c-PDT procedure treatment mild moderate AKs . In addition study include Metvix NDL-PDT arm versus Metvix vehicle cream c PDT ( Placebo ) ass sensitivity trial .</brief_summary>
	<brief_title>Phase 3b Study Metvix NDL-PDT Versus Metvix c-PDT Subjects With Actinic Keratoses</brief_title>
	<detailed_description />
	<mesh_term>Keratosis</mesh_term>
	<mesh_term>Keratosis , Actinic</mesh_term>
	<mesh_term>Methyl 5-aminolevulinate</mesh_term>
	<mesh_term>Aminolevulinic Acid</mesh_term>
	<criteria>Clinical diagnosis mild ( Grade 1 ) and/or moderate ( Grade 2 ) AKs face scalp treat area Subject two symmetrical treat area half scalp two half face exclude ear , chin , bridge nose , eyelid lip inside vermillion border ) : twofold difference term total number lesion two TAs Subject clinical diagnosis least one severe ( Grade 3 ) AK treat area Subject pigment AK treat area Immunocompromised Subject idiopathic , disease specific therapeutic reason Subject porphyria ,</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>actinic keratoses</keyword>
	<keyword>photodynamic therapy</keyword>
	<keyword>natural daylight</keyword>
</DOC>